Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three Generation β-Blockers for Atrial Fibrillation Treatment. | Curr Hypertens Rev | 2023 | 35692167 | PubTator, text mining | PubMed |
| The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases. | Cardiovasc Drugs Ther | 2023 | 34533690 | PubTator, text mining | PubMed |
| Consensus on the Southeast Asian management of hypotension using vasopressors and adjunct modalities during cesarean section under spinal anesthesia. | J Anesth Analg Crit Care | 2022 | 37386598 | PubTator, text mining | PubMed |
| Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion. | Front Cardiovasc Med | 2022 | 36818914 | PubTator, text mining | PubMed |
| Beta-blockers in septic shock: What is new? | J Intensive Med | 2022 | 36789018 | PubTator, text mining | PubMed |
| Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment. | Biomedicines | 2022 | 36672577 | PubTator, text mining | PubMed |
| Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients. | J Clin Med | 2022 | 36615083 | PubTator, text mining | PubMed |
| The des-Arg9-bradykinin/B1R axis: Hepatic damage in COVID-19. | Front Physiol | 2022 | 36601349 | PubTator, text mining | PubMed |
| A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department. | Cureus | 2022 | 36600855 | PubTator, text mining | PubMed |
| Stepwise Reduction of Mycophenolate Mofetil with Conversion to Everolimus for the Treatment of Active BKV in Kidney Transplant Recipients: A Single-Center Experience in Vietnam. | J Clin Med | 2022 | 36555914 | PubTator, text mining | PubMed |
| Elucidation of the Key Therapeutic Targets and Potential Mechanisms of Marmesine against Knee Osteoarthritis via Network Pharmacological Analysis and Molecular Docking. | Comput Math Methods Med | 2022 | 36544567 | PubTator, text mining | PubMed |
| Beta-Adrenergic Receptor Blockade Effects on Cardio-Pulmonary Exercise Testing in Healthy Young Adults: A Randomized, Placebo-Controlled Trial. | Sports Med Open | 2022 | 36538192 | PubTator, text mining | PubMed |
| Cardio-selective versus non-selective β-blockers for cardiovascular events and mortality in long-term dialysis patients: A systematic review and meta-analysis. | PLoS One | 2022 | 36534654 | PubTator, text mining | PubMed |
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. | Front Microbiol | 2022 | 36519165 | PubTator, text mining | PubMed |
| Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice. | J Transl Med | 2022 | 36514072 | PubTator, text mining | PubMed |
| Influences of Intense Physical Effort on the Activity of the Autonomous Nervous System and Stress, as Measured with Photoplethysmography. | Int J Environ Res Public Health | 2022 | 36498140 | PubTator, text mining | PubMed |
| [Research advance of the mechanism and treatment of septic cardiomyopathy]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2022 | 36473575 | PubTator, text mining | PubMed |
| Molecular Advances in SARS-CoV-2: A Brief Update on Transmission, Infection, and Pathology Aspects. | Int J Mol Sci | 2022 | 36430725 | PubTator, text mining | PubMed |
| Altered Urinary Metabolomics in Hereditary Angioedema. | Metabolites | 2022 | 36422280 | PubTator, text mining | PubMed |
| Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease. | Front Med (Lausanne) | 2022 | 36405582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=12